Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy

被引：0
|
作者：
Schmidt, MK
van Sprundel, TC
Rookus, MA
Brohet, R
van Asperen, CJ
Rutgers, EJT
Tollenaar, RAEM
van't Veer, LJ
机构：
[1] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands
[3] Netherlands Canc Inst, Dept Surg, Amsterdam, Netherlands
[4] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands
[5] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands
来源：
BREAST CANCER RESEARCH | 2005年 / 7卷 / Suppl 2期
关键词：
Breast Cancer; Contralateral Breast Cancer; BRCA2 Mutation Carrier; Mutation Testing; Contralateral Prophylactic Mastectomy;
D O I：
10.1186/bcr1096
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [21] Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: A WECARE Study Report
    Bernstein, Jonine L.
    Thomas, Duncan C.
    Shore, Roy E.
    Robson, Mark
    Boice, John D., Jr.
    Stovall, Marilyn
    Andersson, Michael
    Bernstein, Leslie
    Malone, Kathleen E.
    Reiner, Anne S.
    Lynch, Charles F.
    Capanu, Marinela
    Smith, Susan A.
    Tellhed, Lina
    Teraoka, Sharon N.
    Begg, Colin B.
    Olsen, Jorgen H.
    Mellemkjaer, Lene
    Liang, Xiaolin
    Diep, Anh T.
    Borg, Ake
    Concannon, Patrick
    Haile, Robert W.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (14) : 2979 - 2985
  • [22] Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Jacek Gronwald
    Andre Robidoux
    Charmaine Kim-Sing
    Nadine Tung
    Henry T. Lynch
    William D. Foulkes
    Siranoush Manoukian
    Peter Ainsworth
    Susan L. Neuhausen
    Rochelle Demsky
    Andrea Eisen
    Christian F. Singer
    Howard Saal
    Leigha Senter
    Charis Eng
    Jeffrey Weitzel
    Pal Moller
    Dawna M. Gilchrist
    Olufunmilayo Olopade
    Ophira Ginsburg
    Ping Sun
    Tomasz Huzarski
    Jan Lubinski
    Steven A. Narod
    Breast Cancer Research and Treatment, 2014, 146 : 421 - 427
  • [23] Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Gronwald, Jacek
    Robidoux, Andre
    Kim-Sing, Charmaine
    Tung, Nadine
    Lynch, Henry T.
    Foulkes, William D.
    Manoukian, Siranoush
    Ainsworth, Peter
    Neuhausen, Susan L.
    Demsky, Rochelle
    Eisen, Andrea
    Singer, Christian F.
    Saal, Howard
    Senter, Leigha
    Eng, Charis
    Weitzel, Jeffrey
    Moller, Pal
    Gilchrist, Dawna M.
    Olopade, Olufunmilayo
    Ginsburg, Ophira
    Sun, Ping
    Huzarski, Tomasz
    Lubinski, Jan
    Narod, Steven A.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 146 (02) : 421 - 427
  • [24] Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers:: an update
    Gronwald, J
    Tung, N
    Foulkes, WD
    Offit, K
    Gershoni, R
    Daly, M
    Kim-Sing, C
    Olsson, H
    Ainsworth, P
    Eisen, A
    Saal, H
    Friedman, E
    Olopade, O
    Osborne, M
    Weitzel, J
    Lynch, H
    Ghadirian, P
    Lubinski, J
    Sun, P
    Narod, SA
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (09) : 2281 - 2284
  • [25] Defining Variations in Survival of BRCA1 and BRCA2 Mutation Carriers
    Grann, Victor R.
    Parsons, Ramon E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (14): : 1597 - 1598
  • [26] Cancer risks among BRCA1 and BRCA2 mutation carriers
    E Levy-Lahad
    E Friedman
    British Journal of Cancer, 2007, 96 : 11 - 15
  • [27] Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
    Warner, Ellen
    CANCERS, 2018, 10 (12)
  • [28] Cancer risks among BRCA1 and BRCA2 mutation carriers
    Levy-Lahad, E.
    Friedman, E.
    BRITISH JOURNAL OF CANCER, 2007, 96 (01) : 11 - 15
  • [29] Should hysterectomy complement prophylactic salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers?
    Vyarvelska, Iryna
    Rosen, Barry
    Narod, Steven A.
    GYNECOLOGIC ONCOLOGY, 2014, 134 (02) : 219 - 221
  • [30] Clinical relevance of normal and tumour cell radiosensitivity in BRCA1/BRCA2 mutation carriers: A review
    Bernier, Jacques
    Poortmans, Philip
    BREAST, 2015, 24 (02) : 100 - 106
12345